Skip to main content
Log in

Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle disease virus

  • Published:
Glycoconjugate Journal Aims and scope Submit manuscript

Abstract

Viruses of the Paramyxoviridae family are the leading cause of respiratory disease in children. The human parainfluenza viruses (hPIV) are members of the Paramyxovirinae subfamily, which also includes mumps virus, Newcastle disease virus (NDV), Sendai virus (SV) and simian type 5 virus (SV5). On the surface of these viruses is the glycoprotein hemagglutinin-neuraminidase (HN), which is responsible for cell attachment, promotion of fusion and release of progeny virions. This multifunctional nature of HN makes it an attractive target for the development of inhibitors as a treatment for childhood respiratory diseases. Here we report the crystal structure of NDV HN in complex with a derivative of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid, Neu5Ac2en, that has a functional group designed to occupy a large conserved binding pocket around the active site. The purpose of this study was to examine the effect of a bulky hydrophobic group at the O4 position of Neu5Ac2en, given the hydrophobic nature of the binding pocket. This derivative, with a benzyl group added to the O4 position of Neu5Ac2en, has an IC50 of ∼10 μM in a neuraminidase assay against hPIV3 HN. The IC50 value of the parent compound, Neu5Ac2en, in the same assay is ∼25 μM. These results highlight the striking difference between the influenza neuraminidase and paramyxovirus HN active sites, and provide a platform for the development of improved HN inhibitors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. McIntosh, K., Fishaut, M.: Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus. Prog in Medical Virology 26, 94–118 (1980)

    CAS  Google Scholar 

  2. Delage, G., Brochu, P., Pelletier, M., Gasmin, G., Lapoint, N.: Giant-cell pneumonia caused by parainfluenza virus. J. Pediatr. 94, 426–9 (1979)

    CAS  PubMed  Google Scholar 

  3. Lamb, R.A., Kolakofsky, D.: Paramyxoviridae: The viruses and their replication Fields Virology edited by Knipe, D., Howley, P.M. (Lippincott Williams & Wilkins, Philadelphia, USA, 2001) pp. 1305–40

  4. Jackson, G.G., Muldoon, R.L.: Enteroviruses and paramyxoviruses, The University of Chicago Press, Chicago, 1975

    Google Scholar 

  5. Choppin, P.W., Scheid, A.: The role of viral glycoproteins in adsorption, penetration and pathogenicity of viruses. Rev. Infect. Dis. 2, 40–61 (1980)

    CAS  PubMed  Google Scholar 

  6. Hu, X.L., Ray, R., Compans, R.W.: Functional Interactions Between the Fusion Protein and Hemagglutinin—Neuraminidase of Human Parainfluenza Viruses. Journal of Virology 66, 1528–34 (1992)

    CAS  PubMed  Google Scholar 

  7. Crennell, S., Takimoto, T., Portner, A., Taylor, G.: Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nature Structural Biology 7, 1068–74 (2000)

    CAS  PubMed  Google Scholar 

  8. Lawrence, M.C., Borg, N.A., Streltsov, V.A., Pilling, P.A., Epa, V.C., Varghese, J.N., McKimm-Breschkin, J.L., Colman, P.M.: Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III. J. Mol. Biol. 335, 1343–57 (2004)

    Article  CAS  PubMed  Google Scholar 

  9. Yuan, P., Thompson, T.B., Wurzburg, B.A., Paterson, R.G., Lamb, R.A., Jardetzky, T.S.: Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose. Structure (Camb.) 13, 803–15 (2005)

    Article  CAS  Google Scholar 

  10. Thompson, S.D., Laver, W.G., Murti, K.G., Portner, A.: Isolation of a Biologically-Active Soluble Form of the Hemagglutinin—Neuraminidase Protein of Sendai Virus. Journal of Virology 62, 4653–60 (1988)

    CAS  PubMed  Google Scholar 

  11. Connaris, H., Takimoto, T., Russell R., Crennell, S., Moustafa, I., Portner, A., Taylor, G.: Probing the sialic acid binding site of the hemagglutinin-neuraminidase of Newcastle disease virus: Identification of key amino acids involved in cell binding, catalysis, and fusion. J. Virol 76, 1816–24 (2002)

    Article  CAS  PubMed  Google Scholar 

  12. Takimoto, T., Taylor, G.L., Connaris, H.C., Crennell, S.J., Portner, A.: Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion. J. Virol 76, 13028–33 (2002)

    Article  CAS  PubMed  Google Scholar 

  13. Corey, E.A., Mirza, A.M., Levandowsky, E., Iorio, R.M.: Fusion deficiency induced by mutations at the dimer interface in the Newcastle disease virus hemagglutinin-neuraminidase is due to a temperature-dependent defect in receptor binding. J. Virol 77, 6913–22 (2003)

    Article  CAS  PubMed  Google Scholar 

  14. Zaitsev, V., von Itzstein, M., Groves, D.R., Kiefel, M.J., Takimoto, T., Portner, A., Taylor, G.: Second Sialic Acid Binding Site in Newcastle Disease Virus Hemagglutinin-Neuraminidase: Implications for Fusion. J. Virol 78, 3733–41 (2004)

    Article  CAS  PubMed  Google Scholar 

  15. Alymova, I.V., Taylor, G., Takimoto, T., Babu, Y.S., Chenghong, L., Xiaoping, X., Portner, A.: Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo. Antimicrob Agents Chemother 48, (2004)

  16. Takimoto, T., Taylor, G.L., Crennell, S.J., Scroggs, R.A., Portner, A.: Crystallization of Newcastle Disease Virus Hemagglutinin-Neuraminidase Glycoprotein. Virology 270, 208–14 (2000)

    Article  CAS  PubMed  Google Scholar 

  17. Leslie, A.G.W.: Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4 + ESF-EAMCB Bewsletter on Protein Crystallography, 26, (1992)

  18. CCP4. The CCP4 suite: Programs for protein crystallography. Acta Crystallographica D 50, 760–763 (1994)

  19. Brunger, A.T., Adams, P.D., et al.: Crystallography and NMR system: A new software suite for macromolecular structure determination. Acta Crystallographica Section D 54, 905–21 (1998)

    Google Scholar 

  20. Jones, A.T., Zhou, J.Y., Cowan, S.W., Kjeldgaard, M.: Improved methodsfor the building of protein models in electron desnity mps and the location of errors in these models. Acta. Crystallographica A 47, 110–19 (1991)

    Google Scholar 

  21. Schuttelkopf, A.W., van Aalten, D.M.: PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta. Crystallogr. D Biol. Crystallogr. 60, 1355–63 (2004)

    PubMed  Google Scholar 

  22. Taylor, G.: Sialidases: Structures, biological significance and therapeutic potential. Current Opinion in Structural Biology 6, 830–37 (1996)

    Article  CAS  PubMed  Google Scholar 

  23. von Itzstein, M., Wu, W.Y., Kok, G.B., Pegg, M.S., Dyason, J.C., Jin, B., Phan, T.V., Smythe, M.L., White, H.F., Oliver, S.W., Colman, P.M., Varghese, J.N., Ryan, D.M., Woods, J.M., Bethell, R.C., Hotham, V.J., Cameron, J.M., Penn, C.R.: Rational design of potent sialidase-based inhibitors of influenza-virus replication. Nature 363, 418–23 (1993)

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Garry Taylor.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ryan, C., Zaitsev, V., Tindal, D.J. et al. Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle disease virus. Glycoconj J 23, 135–141 (2006). https://doi.org/10.1007/s10719-006-5446-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10719-006-5446-8

Keywords

Navigation